Levonorgestrel IUS (Mirena)
Intrauterine levonorgestrel — LARC; endometrial thinning
Overview
A progestogen-releasing intrauterine device (LARC, 5–8 years depending on brand) that thins the endometrium and thickens cervical mucus. Doubles as treatment for heavy menstrual bleeding and as the progestogen component of HRT — periods usually become light or absent.
Recognise
- LARC; very effective; local progestogen with minimal systemic effect
- Periods become lighter or stop (vs the copper coil which makes them heavier)
- Licensed for heavy menstrual bleeding and for endometrial protection in HRT
- Small risk of uterine perforation at fitting and expulsion
Red flags
- Current breast cancer (UKMEC 4); active pelvic infection/undiagnosed bleeding before fitting
Differentials & how to tell them apart
Investigations
STI risk assessment before fitting; exclude pregnancy and undiagnosed abnormal bleeding; bimanual to assess uterus.
Management
LNG-IUS — contraception that also treats heavy menstrual bleeding / protects endometrium in HRT
- 1Offer as LARC, especially if periods are heavy. Assess STI risk, exclude pregnancy/undiagnosed bleeding, then fit.Gate: Undiagnosed abnormal vaginal bleeding must be investigated BEFORE fitting an IUS/IUD
- 2Persistent pain/abnormal bleeding after fitting → exclude perforation, expulsion, malposition, infection.
Key points
The first-line medical treatment for heavy menstrual bleeding doubles as contraception. Provides the progestogen arm of HRT (endometrial protection).
Monitor & prognosis
Threads check; bleeding pattern; replace at licensed interval.
Rapidly reversible on removal.
Source: FSRH UKMEC 2016; NICE NG88 (heavy menstrual bleeding)